UBS Group AG - 31 Dec 2024 SCHEDULE 13G/A Report for Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01 per share (AMRX)

Filing Manager: UBS Group AG
Reporting Manager: UBS Group AG
Security: Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01 per share
Symbol: AMRX
Disclosed Ownership: 0 shares
Ownership: 0%
Form type: SCHEDULE 13G/A
Filing time: 10 Feb 2025, 08:59:12 UTC
Date of event: 31 Dec 2024
Previous filing: 30 Oct 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
UBS Group AG	0%	0	0	0	Andrew Johnson	Director